Skip to main content

AstraZeneca PLC Investor Investigation

  • If you are a current investor in AstraZeneca PLC (NYSE: AZN) and/or hold AstraZeneca PLC (NYSE: AZN) since 2005, you should contact the Shareholders Foundation, Inc. immediately!

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of current investors in AstraZeneca PLC (NYSE: AZN) over possible Securities Laws violations was announced. On February 26, 2009, AstraZeneca PLC agreed to unseal documents related to its multi-billion-dollar antipsychotic drug Seroquel concerning lawsuits pending in a U.S. federal court brought by thousands of plaintiffs alleging to be harmed by Seroquel. O...



You must register (for free) or login to view the entire investigation.